BioMarin CEO on hemophilia treatment success
Share

BioMarin CEO on hemophilia treatment success

BioMarin CEO Jean-Jacques Bienaime discusses the company's hemophilia A treatment at J.P. Morgan Health in San Francisco.
06:47
Mon, Jan 8 20182:00 PM EST